Data Foundry

Drug recalls 2018

Zoledronic Acid Injection — Class III drug recall D-0103-2019

Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2018-10-03, distributed nationwide. Failed Impurities/Degradation Specifications: OOS for unknown impurities.

Recall numberD-0103-2019
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDr. Reddy's Laboratories, Inc., Princeton, NJ, United States
Recall initiated2018-09-12
Classified2018-10-26
Reported by FDA2018-10-03
Terminated2020-03-03
DistributedNationwide (US)
Quantity59,468 vials
Reason classesspecification failure
NDC55111-0688-52
Lot numbersBS633, BS701, BS702, BS703, BS708, BS709, BS711, BS712, BS713, BS714, BS715, BS726, BS727, BS728, BS729, BS730, BS801
Expiration dates2018-09, 2018-12, 2019-03, 2019-06, 2019-07, 2020-03

Product

Zoledronic Acid Injection, 5mg/100 mL (0.05 mg/mL) 100ml vial, Rx Only. Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. NDC 55111-688-52

Reason for recall

Failed Impurities/Degradation Specifications: OOS for unknown impurities.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0103-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.